Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 14:12:983805.
doi: 10.3389/fonc.2022.983805. eCollection 2022.

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer

Yang Luan  1 , Qin Xiao  1 , Xue-Fei Ding  1 , Liang-Yong Zhu  1 , Yue-Xing Han  1 , Hao-Peng Chen  1 , Tian-Bao Huang  1 , Sheng-Ming Lu  1
Affiliations

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer

Yang Luan et al. Front Oncol. .

Abstract

Objective: To explore the feasibility of single-point prostate biopsy in elderly patients with highly suspected prostate cancer.

Methods: Forty-three patients with a prostate imaging reporting and data system score (PI-RADS) of 5, age ≥ 80 years and/or PSA ≥ 100 ng/ml and/or Eastern Cooperative Oncology Group score ≥ 2 were enrolled in our hospital from March 2020 to June 2022. Targeted surgery of these patients was performed using only precise local anesthesia in the biopsy area. The biopsy tissues were examined by intraoperative frozen section examination (IFSE). If the result of IFSE was negative, traditional systematic biopsy and further routine pathological examination were performed. The positive rate of biopsy, operation time, complications and pain score were recorded.

Results: The positive rate of prostate biopsy was 94.7%. The results of IFSE in two patients were negative, and the routine pathological results of further systematic biopsy of those patients were also negative. The visual analog scale and visual numeric scale were 2 (2-4) and 3 (2-3), respectively, during the biopsy procedure. The mean time of operation was 8.5 ± 2.1 min from the beginning of anesthesia to the end of biopsy. It took 35.3 ± 18.7 minutes to obtain the pathological report of IFSE. The incidences of complication hematuria and urinary retention were 10.5% and 2.6%, respectively.

Conclusion: For elderly patients with highly suspected prostate cancer, single-point prostate biopsy can be used to quickly and safely obtain pathological results.

Keywords: biopsy; diagnosis; pathology; prostate cancer; quickly.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The flow diagram of the study.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, et al. . Cancer incidence and mortality in China. Chin J Cancer Res (2018) 30:1–12. doi: 10.21147/j.issn.1000-9604.2018.01.01 - DOI - PMC - PubMed
    1. Fu ZT, Guo XL, Zhang SW, Zheng RS, Zeng HM, Chen R, et al. . Statistical analysis of incidence and mortality of prostate cancer in China, 2015. Chin J Oncol (2020) 42(09):718–22. doi: 10.3760/cma.j.cn112152-20200313-00200 - DOI - PubMed
    1. Han J, Yang DL, Liu JH, Li BH, Kan Y, Ma S, et al. . Family-centered psychological support helps improve illness cognition and quality of life in patients with advanced prostate cancer. Natl J Androl (2020) 505–12. doi: 10.13263/j.cnki.nja.2020.06.004 - DOI - PubMed
    1. Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, et al. . Oral relugolix for androgen-deprivation therapy in advanced prostate cancer. N Engl J Med (2020) 382:2187–96. doi: 10.1056/NEJMoa2004325 - DOI - PubMed
    1. Muniyan S, Rachagani S, Parte S, Halder S, Seshacharyulu P, Kshirsagar P, et al. . Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO-cGMP signaling. Clin Cancer Res (2020) 26:5720–34. doi: 10.1158/1078-0432.CCR-20-1569 - DOI - PMC - PubMed